Pliant Therapeutics Appoints Minnie Kuo as Chief Operating Officer
I'm PortAI, I can summarize articles.
Pliant Therapeutics Inc. has appointed Minnie Kuo as Chief Operating Officer, effective immediately. Kuo, who joined the company in September 2023 as Chief Development Officer, brings over 20 years of experience in biotechnology and pharmaceuticals, with previous leadership roles at Vir Biotechnology, Nektar Therapeutics, and Gilead Sciences.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments